| Literature DB >> 28149885 |
Sherly Pardo-Reoyo1, J L Roig-Lopez2, Eddy S Yang2.
Abstract
Radiotherapy is a mainstay of treatment for head and neck cancer. However, the morbidity of treatment remains a clinical challenge. Molecular profiling has provided further insight into tumor biology and tumor sensitivity to radiation, and this information could be used to personalize treatment. In this review, we discuss published signatures of radiosensitivity and discuss the pathways that may be important in dictating radiation sensitivity. Applications of these signatures could result in less morbidity if dose de-escalation efforts are successful.Entities:
Keywords: Head and neck cancer; biomarkers; epithelial-mesenchymal transition (EMT); microRNA; radiation sensitivity
Year: 2016 PMID: 28149885 PMCID: PMC5233482 DOI: 10.21037/atm.2016.12.45
Source DB: PubMed Journal: Ann Transl Med ISSN: 2305-5839